Serveur d'exploration Tocilizumab

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

Eléments de l'association

Région de Kantō222
Katsuya Suzuki10
Région de Kantō Sauf Katsuya Suzuki" 216
Katsuya Suzuki Sauf Région de Kantō" 4
Région de Kantō Et Katsuya Suzuki 6
Région de Kantō Ou Katsuya Suzuki 226
Corpus6869
\n\n\n\n \n

List of bibliographic references

Number of relevant bibliographic references: 6.
Ident.Authors (with country if any)Title
000298 Yoshikazu Nakaoka ; Mitsuaki Isobe ; Yoshiya Tanaka ; Tomonori Ishii ; Seido Ooka ; Hiroaki Niiro [Japon] ; Naoto Tamura ; Shogo Banno ; Hajime Yoshifuji [Japon] ; Yasushi Sakata ; Atsushi Kawakami ; Tatsuya Atsumi ; Shunsuke Furuta ; Hitoshi Kohsaka ; Katsuya Suzuki ; Ryoki Hara ; Yasuhiro Maejima ; Hiroshi Tsukamoto ; Yoshinari Takasaki ; Katsuhisa Yamashita ; Norihiro Okada ; Shinji Yamakido ; Syuji Takei ; Shumpei Yokota [Japon] ; Norihiro Nishimoto [Japon]Long-term efficacy and safety of tocilizumab in refractory Takayasu arteritis: final results of the randomized controlled phase 3 TAKT study.
000844 Kotaro Matsumoto [Japon] ; Katsuya Suzuki [Japon] ; Keiko Yoshimoto [Japon] ; Noriyasu Seki ; Hideto Tsujimoto ; Kenji Chiba ; Tsutomu Takeuchi [Japon]Significant association between clinical characteristics and changes in peripheral immuno-phenotype in large vessel vasculitis
001A46 Atsuko Murota [Japon] ; Katsuya Suzuki [Japon] ; Yoshiaki Kassai [Japon] ; Takahiro Miyazaki [Japon] ; Rimpei Morita [Japon] ; Yasushi Kondo [Japon] ; Masaru Takeshita [Japon] ; Yasuo Niki [Japon] ; Akihiko Yoshimura [Japon] ; Tsutomu Takeuchi [Japon]Serum proteomic analysis identifies interleukin 16 as a biomarker for clinical response during early treatment of rheumatoid arthritis.
001E99 Ho Namkoong [Japon] ; Sadatomo Tasaka [Japon] ; Mitsuhiro Akiyama [Japon] ; Kazuma Yagi [Japon] ; Makoto Ishii [Japon] ; Katsuya Suzuki [Japon] ; Mitsutomo Kohno [Japon] ; Naoki Hasegawa [Japon] ; Tsutomu Takeuchi [Japon] ; Tomoko Betsuyaku [Japon]Successful resumption of tocilizumab for rheumatoid arthritis after resection of a pulmonary Mycobacterium avium complex lesion: a case report.
001F75 Minoru Fujimoto [Japon] ; Satoshi Serada [Japon] ; Katsuya Suzuki [Japon] ; Ayumi Nishikawa [Japon] ; Atsushi Ogata [Japon] ; Toshihiro Nanki [Japon] ; Kunihiro Hattori [Japon] ; Hitoshi Kohsaka [Japon] ; Nobuyuki Miyasaka [Japon] ; Tsutomu Takeuchi [Japon] ; Tetsuji Naka [Japon]Leucine-rich α2 -glycoprotein as a potential biomarker for joint inflammation during anti-interleukin-6 biologic therapy in rheumatoid arthritis.
004387 Masako Tsukamoto [Japon] ; Katsuya Suzuki [Japon] ; Noriyuki Seta [Japon] ; Tsutomi Takeuchi [Japon]Increased circulating CD14brightCD16+ intermediate monocytes are regulated by TNF-α and IL-6 axis in accordance with disease activity in patients with rheumatoid arthritis.

Wicri

This area was generated with Dilib version V0.6.34.
Data generation: Fri May 22 09:34:00 2020. Site generation: Sun Mar 28 09:01:19 2021